v3.26.1
Consolidated Statements of Operations and Comprehensive (Loss) Income - USD ($)
$ in Thousands
5 Months Ended 7 Months Ended 12 Months Ended
Dec. 31, 2024
Jul. 30, 2024
Dec. 31, 2025
Financial Designation, Predecessor and Successor [Fixed List] Successor    
Revenue $ 269 $ 333 $ 0
Cost of revenue and operating expenses:      
Cost of revenue 1,937 1,381 684
Research and development 4,634 7,585 10,639
Selling, general, and administrative 6,976 13,047 10,567
Impairment - Goodwill 30,324 0 0
Impairment - Intangibles assets, net 18,878    
Total cost of revenue and operating expenses 62,749 22,013 21,890
Loss from operations (62,480) (21,680) (21,890)
Other (expense) income:      
Interest expense (1,105) (1,818) (2,906)
Interest income 420 3 477
Other (expense) income, net 1,897 (33) 195
Total other (loss) income, net 8,717 402 (3,194)
Net loss (53,763) (21,278) (25,084)
Other comprehensive loss:      
Foreign currency translation adjustment 1 3 (100)
Comprehensive loss $ (53,762) $ (21,275) $ (25,184)
Basic net loss per share (in dollars per share) $ (3.38) $ (26.08) $ (1.51)
Diluted net loss per share (in dollars per share) $ (3.7) $ (26.08) $ (1.51)
Weighted-average shares outstanding - Basic (in shares) 14,772,692 815,854 16,577,126
Weighted-average shares outstanding - Diluted (in shares) 14,772,692 815,854 16,577,126
Convertible notes      
Other (expense) income:      
Fair value measurement adjustments $ 929 $ 2,059 $ (980)
Warrant liabilities      
Other (expense) income:      
Fair value measurement adjustments $ 6,576 $ 191 $ 20